申请人:Pfizer Inc
公开号:US07902373B2
公开(公告)日:2011-03-08
The present invention relates to compounds of formula (I)
and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
本发明涉及公式(I)的化合物及其药学上可接受的盐和溶剂化物,其中取代基如本文所定义,包含该类化合物的组合物以及该类化合物在治疗哮喘等各种疾病和症状方面的用途。